Cargando…
A review of cutting-edge therapies for hepatocellular carcinoma (HCC): Perspectives from patents
Rationale: Hepatocellular carcinoma (HCC) is a challenging disease due to its heterogenous etiology. Several breakthroughs have occurred in treatment of HCC, associated with an enormous number of patent publications for a variety of HCC treatment modalities. As patents can provide valuable informati...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Ivyspring International Publisher
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364461/ https://www.ncbi.nlm.nih.gov/pubmed/34400877 http://dx.doi.org/10.7150/ijms.59930 |